GELSYN-3
FDA premarket approval P110005/S006 · decided 2020-10-08
Approval details
- PMA number
- P110005
- Supplement
- S006
- Supplement type
- 30-Day Notice
- Supplement reason
- Process Change - Manufacturer/Sterilizer/Packager/Supplier
- Trade name
- GELSYN-3
- Generic name
- Acid, hyaluronic, intraarticular
- Applicant
- Ibsa Institut Biochimique SA
- Date received
- 2020-09-04
- Decision date
- 2020-10-08
- Days to decision
- 34 days
- Decision code
- OK30
- Product code
- MOZ
- Advisory committee
- Orthopedic
- Expedited review
- No
- Location
- Lugano Ticino
- Statement
- Change to the bacterial endotoxins (BE) acceptance limit for the glass syringe associated with change in BE test method.
Class III intelligence, same tools
PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.